Showing 1471 - 1480 of 2684 results

JAMDA

October 28, 2019

Deprescribing as a Clinical Improvement Focus

Polypharmacy is a concern in the practice of geriatrics because of consequences such as adverse drug events and poorer quality of life. Deprescribing, a response to polypharmacy, refers to the systematic, programmed, and appropriate reduction in drug number and dose. Although now broadly recognized, challe...
Policy Snapshot

November 1, 2024

Ask Congress to Support New Bill Preventing Medicare Payment Cuts

Without congressional action, the budget neutrality requirements mandated by the CY 2025 Medicare Physician Fee Schedule (MPFS) Proposed Rule will cause the Conversion Factor (CF) to decrease from approximately $33.29 to $32.36 starting January 1, 2025. This 2.8% reduction marks the fifth consecutive year ...
CPG Pocket Guides

3Ds: Delirium, Dementia and Depression Pocket Guide (Set of 5)

As the population ages, many adults will suffer one or more of the 3Ds: Delirium, Dementia and Depression. At times, these symptoms overlap and occur simultaneously. Recognize the difference with this pocket guide reference tool and provide proper treatment. Know what surveyors are looking for and learn th...
Basic Page

Drive to Deprescribe (D2D) Courses

Safely reduce polypharmacy and optimize medication use in PALTC settings with our Drive to Deprescribe interactive courses and on-demand webinars.

 

Advocacy Summit 300x300

 

PALTC26 Save the Date 300x300

Advertisement

 

Advertisement